Strength in Numbers: Discovery in Oral Medicine

II. Advances in Biological Agents in the Treatment of Connective Tissue Disease and their Influence on the Practice of Oral Medicine

In recent years there have been remarkable advances in the use of biological agents in the management of connective tissue disorders, largely due to the conduct of well-designed multicenter clinical trials. This talk summarizes the design, organization, and experiences from hallmark trials and highlights opportunities for collaboration with oral medicine. 

Learning Objectives:

  1. Provide an overview of the expanding utilization of new biological agents in the treatment of immune-mediated connective tissue diseases
  2. Understand the clinical trial designs used in studies evaluating biological agents for treatment of connective tissue diseases
  3. Consider opportunities for collaborative trials in the field of oral medicine 

John Reveille, MD
Division Director, Vice-Chair, Professor, Rheumatology and Clinical Immunogenetics
University of Texas